MoneyWorks4Me

Ami Organics informs about statement of deviation or variation

29 Oct 2024 Evaluate
Ami Organics has informed that it enclosed the statement of deviation(s) or variation(s) in utilisation of Preferential Issue proceeds, for quarter ended September 30, 2024 pertaining to the Preferential Issue of equity shares of the Company in the prescribed format. We confirm that, as at September 30, 2024 there has not been any deviation(s) or variation(s) in the utilization of net proceeds of Preferential Issue of equity shares allotted on May 31, 2024.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..